(FC) Bioquímica y Genética

2023

1. A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma

   Cells, Vol. 12, Núm. 12

2. A Multimodal Scaffold for SDF1 Delivery Improves Cardiac Function in a Rat Subacute Myocardial Infarct Model

   ACS Applied Materials and Interfaces, Vol. 15, Núm. 44, pp. 50638-50651

3. A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease

   Science translational medicine, Vol. 15, Núm. 713, pp. eabq5930

4. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans

   Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 709-726

5. Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma

   Hepatology (Baltimore, Md.), Vol. 78, Núm. 6, pp. 1742-1754

6. Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation

   Blood, Vol. 141, Núm. 9, pp. 1047-1059

7. Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury

   European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 83-91

8. Analysis of common biomarkers in capillary blood in routine clinical laboratory. Preanalytical and analytical comparison with venous blood

   Diagnosis, Vol. 10, Núm. 3, pp. 281-297

9. Antifibrogenic and apoptotic effects of Ocoxin in cultured rat hepatic stellate cells

   Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 881-890

10. Biochemical biomarkers for multiple sclerosis

    Clinica Chimica Acta, Vol. 548

11. Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress

    Cells, Vol. 12, Núm. 18

12. Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes

    Scientific Reports, Vol. 13, Núm. 1

13. Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease

    JHEP Reports, Vol. 5, Núm. 5

14. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma

    Clinica Chimica Acta, Vol. 548

15. Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma

    Molecular cancer therapeutics, Vol. 22, Núm. 3, pp. 343-356

16. Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group

    Blood Cancer Journal, Vol. 13, Núm. 1

17. Compartmentalized drug localization studies in extracellular vesicles for anticancer therapy

    Nanoscale Advances, Vol. 5, Núm. 24, pp. 6830-6836

18. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

19. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

20. Effect of Low Testosterone Levels on the Expression of Proliferator-Activated Receptor Alpha in Female Patients with Primary Biliary Cholangitis

    Cells, Vol. 12, Núm. 18